Insulet Corp (PODD) - Financial and Strategic SWOT Analysis Review
July 2019
50
About the Report
About the Report
Insulet Corp (PODD)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description-A detailed description of the company's operations and business divisions.
- Corporate strategy-Analyst's summarization of the company's business strategy.
- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history-Progression of key events associated with the company.
- Major products and services-A list of major products, services and brands of the company.
- Key competitors-A list of key competitors to the company.
- Key employees-A list of the key executives of the company.
- Executive biographies-A brief summary of the executives' employment history.
- Key operational heads-A list of personnel heading key departments/functions.
- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Insulet Corp (Insulet) is a medical device company that develops, manufactures and distributes insulin management systems for diabetic patients. Its OmniPod insulin management system is a continuous insulin delivery system for insulin dependent diabetics. Omnipod system consists of a disposable self-adhesive tubeless insulin infusion device, OmniPod, and a handheld wireless device, Personal Diabetes Manager. The company also works in partnership with biotechnology and pharmaceutical companies that utilize the customized form of its Omnipod system to deliver drugs at specified intervals of time at predetermined doses. The company markets and sells its products directly and through distribution partners in North America, Asia and Europe. Insulet is headquartered in Billerica, Massachusetts, the US.
Insulet Corp Key Recent Developments
May 02,2019: Insulet celebrates new global headquarters and U.S. manufacturing facility in Acton, MA
May 02,2019: Insulet Reports First Quarter 2019 Revenue of USD 159.6 Million, an Increase of 29% Year-Over-Year
Feb 25,2019: Insulet announces fourth quarter 2018 revenue of USD 164.9 million, up 26% year-over-year, and full year 2018 revenue of USD 563.8 million, up 22%
Jan 28,2019: Insulet names Corinne Nevinny as board director
Jan 07,2019: Insulet names Wayde McMillan as Chief Financial Officer
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Products
Products
Insulet Corp, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts
Companies
West Pharmaceutical Services Inc
Valeritas Inc
Tandem Diabetes Care Inc
Owen Mumford Inc
Medtronic MiniMed Inc
Table of Contents
Table of Contents
Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1-About the Company
Insulet Corp-Key Facts
Insulet Corp-Key Employees
Insulet Corp-Key Employee Biographies
Insulet Corp-Major Products and Services
Insulet Corp-History
Insulet Corp-Company Statement
Insulet Corp-Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2-Company Analysis
Company Overview
Insulet Corp-Business Description
Business Segment: Drug Delivery
Performance
Business Segment: International Omnipod
Performance
Business Segment: US Omnipod
Performance
Geographical Segment: All other
Performance
Geographical Segment: United States
Performance
R&D Overview
Insulet Corp-Corporate Strategy
Insulet Corp-SWOT Analysis
SWOT Analysis-Overview
Insulet Corp-Strengths
Insulet Corp-Weaknesses
Insulet Corp-Opportunities
Insulet Corp-Threats
Insulet Corp-Key Competitors
Section 3-Company Financial Ratios
Financial Ratios-Capital Market Ratios
Financial Ratios-Annual Ratios
Performance Chart
Financial Performance
Financial Ratios-Interim Ratios
Financial Ratios-Ratio Charts
Section 4-Company's Lifesciences Financial Deals and Alliances
Insulet Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019
Insulet Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019
Insulet Corp, Recent Deals Summary
Section 5-Company's Recent Developments
May 02, 2019: Insulet celebrates new global headquarters and U.S. manufacturing facility in Acton, MA
May 02, 2019: Insulet Reports First Quarter 2019 Revenue of USD 159.6 Million, an Increase of 29% Year-Over-Year
Feb 25, 2019: Insulet announces fourth quarter 2018 revenue of USD 164.9 million, up 26% year-over-year, and full year 2018 revenue of USD 563.8 million, up 22%
Jan 28, 2019: Insulet names Corinne Nevinny as board director
Jan 07, 2019: Insulet names Wayde McMillan as Chief Financial Officer
Nov 01, 2018: Insulet reports third quarter 2018 revenue of USD 151.1 million, up 24% year-over-year, and gross margin over 67%, up 700 basis points
Sep 11, 2018: Insulet Appoints Shacey Petrovic as Chief Executive Officer
Sep 10, 2018: Insulet announces Shacey Petrovic, President and COO, promoted to CEO, effective January 1, 2019; Patrick Sullivan will retire as Chairman and CEO at the end of 2018
Aug 02, 2018: Insulet Reports second quarter 2018 revenue of USD 124.3 million, up 13% year-over-year, and gross margin of 66%, up 710 basis points
May 03, 2018: Insulet Reports First Quarter 2018 Financial Results
Section 6-Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Figure
List of Figures
Insulet Corp, Performance Chart (2014-2018)
Insulet Corp, Ratio Charts
Insulet Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019
Insulet Corp, Medical Equipment, Deals by Type, 2013 to YTD 2019
List of Table
List of Tables
Insulet Corp, Key Facts
Insulet Corp, Key Employees
Insulet Corp, Key Employee Biographies
Insulet Corp, Major Products and Services
Insulet Corp, History
Insulet Corp, Other Locations
Insulet Corp, Subsidiaries
Insulet Corp, Key Competitors
Insulet Corp, Ratios based on current share price
Insulet Corp, Annual Ratios
Insulet Corp, Annual Ratios (Cont...1)
Insulet Corp, Interim Ratios
Insulet Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019
Insulet Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019
Insulet Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.